Nepodin

Nepodin

SCHEMBL1673268

CC(=O)c1c(C)cc2cccc(O)c2c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
ALDH1A1 P00352 2/20 0.53
MCL1 Q07820 2/20 0.53
DNMT1 P26358 1/20 0.53
CACNA1B Q00975 1/20 0.53
APBA1 Q02410 1/20 0.53
APOBEC3G Q9HC16 1/20 0.53
THRB P10828 2/20 0.50
MAOA P21397 2/20 0.45
MAOB P27338 1/20 0.43
MAPT P10636 3/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 2/20 0.41
NSD2 O96028 2/20 0.41
POLB P06746 2/20 0.41
CYP3A4 P08684 2/20 0.41
HPGD P15428 2/20 0.41
INPPL1 O15357 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nepodin SCHEMBL30189621 1.00 MEN1 (0.53) MEN1KMT2AALDH1A1MCL1DNMT1
SCHEMBL20020387 0.83 MEN1 (0.46) MEN1KMT2AALDH1A1MCL1DNMT1
SCHEMBL20020937 0.81 MAPT (0.47) MAPTGAACYP3A4RECQL
SCHEMBL15782873 0.81 MEN1 (0.50) MEN1KMT2AALDH1A1MCL1DNMT1
SCHEMBL12800165 0.80 MEN1 (0.49) MEN1KMT2AALDH1A1MCL1DNMT1
SCHEMBL29437881 0.78 HSD17B1 (0.36) MEN1KMT2AALDH1A1THRBMAPT
SCHEMBL12800168 0.78 CYP3A4 (0.52) MEN1KMT2AALDH1A1POLBCYP3A4
SCHEMBL4742401 0.78 HSD17B1 (0.36) MEN1KMT2AALDH1A1THRBMAPT
SCHEMBL1672199 0.78 SELL (0.39) MEN1KMT2ATHRBMAPTGAA
SCHEMBL16433056 0.77 MEN1 (0.46) MEN1KMT2AALDH1A1MCL1DNMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488152-B1 COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION OREAL (FR) 2018-04-04 EP claimed
US-8551189-B2 Composition comprising at least one 1,8-dihydroxynaphthalene derivative and at least one basifying agent different from aqueous ammonia, process for dyeing keratin fibres using the composition L'OREAL (FR) 2013-10-08 US claimed
EP-2488152-A2 COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION L'Oréal (FR) 2012-08-22 EP claimed
WO-2011045403-A2 COMPOSITION COMPRISING AT LEAST ONE 1,8-DIHYDROXYNAPHTHALENE DERIVATIVE AND AT LEAST ONE BASIFYING AGENT DIFFERENT FROM AQUEOUS AMMONIA, PROCESS FOR DYEING KERATIN FIBRES USING THE COMPOSITION L'OREAL (FR) 2011-04-21 WO claimed
JP-63088113-A None JP disclosed
JP-63088111-A None JP disclosed
CN-118307411-A Preparation method of 2-acyl naphthol compound 西北工业大学 2024-07-09 CN disclosed
CN-118045123-A Rumex acetosa traditional Chinese medicine composition and application thereof 三门峡速达绿色能源科技有限公司 2024-05-17 CN disclosed
CN-116813676-B Rumex plant extract and active compound, and preparation method and application thereof 中国科学院昆明植物研究所 2024-03-19 CN disclosed
CN-116813676-A Rumex plant extract and active compound, and preparation method and application thereof 中国科学院昆明植物研究所 2023-09-29 CN disclosed
CN-116172925-A Plant extract for treating dandruff caused by fungi 赤峰福纳康生物技术有限公司 2023-05-30 CN disclosed
US-20230148620-A1 STABILIZED OIL AND METHODS OF MAKING THE SAME CARGILL, INCORPORATED (US) 2023-05-18 US disclosed
US-6800615-B2 PARASITICIDES, NEMATOCIDES BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-10-05 US disclosed
US-20040152645-A1 Antihelminthic anthraquinones and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-08-05 US disclosed
US-20040116361-A1 Antihelminthic anthraquinones and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-06-17 US disclosed
US-20040106686-A1 Antihelminthic anthraquinones and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2004-06-03 US disclosed
US-20030229032-A1 Antihelminthic anthraquinones and method of use thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2003-12-11 US disclosed
WO-2003089577-A2 ANTIHELMINTHIC ANTHRAQUINONES AND METHOD OF USE THEREOF MICHIGAN STATE UNIVERSITY (US) 2003-10-30 WO disclosed
JP-S6388113-A HAIR COSMETIC SHISEIDO CO LTD 1988-04-19 JP disclosed
JP-S6388111-A MAKE-UP COSMETIC SHISEIDO CO LTD 1988-04-19 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229032-A1 Antihelminthic anthraquinones and method of use thereof HRH2, HRH3, HRH1 MEN1 3190/4885KMT2A 703/4885ALDH1A1 102/4885
US-20040152645-A1 Antihelminthic anthraquinones and method of use thereof HRH2, HRH3, HRH1 MEN1 3190/4885KMT2A 703/4885ALDH1A1 102/4885
US-20040106686-A1 Antihelminthic anthraquinones and method of use thereof HRH2, HRH3, HRH1 MEN1 3190/4885KMT2A 703/4885ALDH1A1 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.